What an incredible evening! We’re honored to share that MyCural Therapeutics was awarded “Disruptor of the Year”, along with a grant of 100,000 SEK for our groundbreaking work in developing a potential disruptive cancer therapy targeting the MYC oncoprotein.
The event brought together over 600 people — founders, researchers, investors, and changemakers — all united by a shared belief in the power of innovation and collaboration.
A heartfelt thank you to the organizers, sponsors, and partners who made this evening possible, and to everyone who came by the Startup Hub, watched our pitch, and shared ideas and energy with us.
This award is a strong reminder that bold science paired with purpose-driven collaboration truly makes an impact. We’re more motivated than ever to continue advancing therapies that can transform the future of cancer care.
Let’s keep building the future — together
Read more here: https://lnkd.in/djegxGUH
